RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies
Phase 1
Terminated
- Conditions
- Non-Hodgkin's Lymphoma RefractoryFollicular LymphomaMantle Cell LymphomaNon-Hodgkin's Lymphoma, RelapsedPrimary Mediastinal Large B Cell LymphomaB-cell Acute Lymphoblastic LeukemiaDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma
- Interventions
- Biological: RPM CD19-mbIL15-CAR-T cells
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- Eden BioCell Ltd.
- Target Recruit Count
- 2
- Registration Number
- NCT04844086
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
© Copyright 2025. All Rights Reserved by MedPath